Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Financial Flexibility Index
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Financial Flexibility Index of 0.30x as of September 2024. Free cash flow of TL36.27 Million (operating CF TL33.37 Million minus capex TL2.91 Million) represents 0% of total liabilities (TL120.48 Million). Check ONCSM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Financial Flexibility Index (2020–2023)
Historical Financial Flexibility Index trend for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) cash conversion ratio.
Annual Financial Flexibility Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Year-by-year free cash flow to debt coverage for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. Explore ONCSM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TRY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.06x | TL-6.54 Million | TL-38.10 Million | TL106.61 Million | ▼ -109.8% |
| 2022 | 0.63x | TL78.71 Million | TL52.69 Million | TL125.50 Million | ▼ -38.4% |
| 2021 | 1.02x | TL51.68 Million | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL19.41 Million | TL56.11 Million | — |